Lysophosphatidic acid: A potential mediator of osteoblast-osteoclast signaling in bone

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1831, Issue 1, 2013, Pages 109-116

  Sims, Stephen M ^a   Panupinthu, Nattapon ^a,b   Lapierre, Danielle M ^a,c   Pereverzev, Alexey ^a   Dixon, S Jeffrey ^a  

^a WESTERN UNIVERSITY   (Canada)

^b UNIVERSITY OF TEXAS   (United States)

^c NORTHERN ONTARIO SCHOOL OF MEDICINE   (Canada)

Author keywords

Apoptosis; Cytosolic calcium; Lysophosphatidic acid; Osteoblast; Osteoclast; Paracrine

Indexed keywords

CALCITONIN; CALCIUM; INTERLEUKIN 6; LYSOPHOSPHATIDIC ACID; PHOSPHOLIPASE; PURINERGIC P2X7 RECEPTOR;

AUTOIMMUNE DISEASE; BONE DEVELOPMENT; BREAST METASTASIS; CELL DEATH; CELL DIFFERENTIATION; CELL LEVEL; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CELLULAR DISTRIBUTION; CRANIOFACIAL MALFORMATION; ENZYME ACTIVATION; GENE DELETION; METABOLIC BONE DISEASE; METASTASIS; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PERIOSTEUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; WOUND HEALING;

ANIMALS; BONE AND BONES; HUMANS; LYSOPHOSPHOLIPIDS; OSTEOBLASTS; OSTEOCLASTS; RECEPTORS, LYSOPHOSPHATIDIC ACID; RECEPTORS, PURINERGIC P2X7; SIGNAL TRANSDUCTION;

EID: 84868539349     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2012.08.001     Document Type: Review

References (66)

1. D.V. Novack, and S.L. Teitelbaum The osteoclast: friend or foe? Annu. Rev. Pathol. 3 2008 457 484
2. A. Teti Bone development: overview of bone cells and signaling Curr. Osteoporos. Rep. 9 2011 264 273
3. S.C. Manolagas Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis Endocr. Rev. 21 2000 115 137
4. X. Feng, and J.M. McDonald Disorders of bone remodeling Annu. Rev. Pathol. 6 2011 121 145
5. S. Hosogaya, Y. Yatomi, K. Nakamura, R. Ohkawa, S. Okubo, H. Yokota, M. Ohta, H. Yamazaki, T. Koike, and Y. Ozaki Measurement of plasma lysophosphatidic acid concentration in healthy subjects: strong correlation with lysophospholipase D activity Ann. Clin. Biochem. 45 2008 364 368
6. S.E. Gardell, A.E. Dubin, and J. Chun Emerging medicinal roles for lysophospholipid signaling Trends Mol. Med. 12 2006 65 75
7. J.W. Choi, D.R. Herr, K. Noguchi, Y.C. Yung, C.W. Lee, T. Mutoh, M.E. Lin, S.T. Teo, K.E. Park, A.N. Mosley, and J. Chun LPA receptors: subtypes and biological actions Annu. Rev. Pharmacol. Toxicol. 50 2010 157 186
8. J. Chun, T. Hla, K.R. Lynch, S. Spiegel, and W.H. Moolenaar International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature Pharmacol. Rev. 62 2010 579 587
9. D. Meyer zu Heringdorf, and K.H. Jakobs Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism Biochim. Biophys. Acta 1768 2007 923 940
10. i-inactivated CHO cells Exp. Cell Res. 312 2006 1899 1908
11. J. Blackburn, and J.P. Mansell The emerging role of lysophosphatidic acid (LPA) in skeletal biology Bone 50 2012 756 762
12. Y. Aki, A. Kondo, H. Nakamura, and A. Togari Lysophosphatidic acid-stimulated interleukin-6 and -8 synthesis through LPA1 receptors on human osteoblasts Arch. Oral Biol. 53 2008 207 213
13. C. Zhao, M.J. Fernandes, G.D. Prestwich, M. Turgeon, J. Di Battista, T. Clair, P.E. Poubelle, and S.G. Bourgoin Regulation of lysophosphatidic acid receptor expression and function in human synoviocytes: implications for rheumatoid arthritis? Mol. Pharmacol. 73 2008 587 600
14. S.G. Bourgoin, and C. Zhao Autotaxin and lysophospholipids in rheumatoid arthritis Curr. Opin. Investig. Drugs 11 2010 515 526
15. S.J. Dixon, and S.M. Sims P2 purinergic receptors on osteoblasts and osteoclasts: potential targets for drug development Drug Dev. Res. 49 2000 187 200
16. M.W. Grol, N. Panupinthu, J. Korcok, S.M. Sims, and S.J. Dixon Expression, signaling, and function of P2X7 receptors in bone Purinergic Signal 5 2009 205 221
17. J.P. Reyes, S.M. Sims, and S.J. Dixon P2 receptor expression, signaling and function in osteoclasts Front. Biosci. (Schol. Ed.) 3 2011 1101 1118
18. W.R. Thompson, C.T. Rubin, and J. Rubin Mechanical regulation of signaling pathways in bone Gene 503 2012 179 193
19. M. Romanello, B. Pani, M. Bicego, and P. D'Andrea Mechanically induced ATP release from human osteoblastic cells Biochem. Biophys. Res. Commun. 289 2001 1275 1281
20. D.C. Genetos, D.J. Geist, D. Liu, H.J. Donahue, and R.L. Duncan Fluid shear-induced ATP secretion mediates prostaglandin release in MC3T3-E1 osteoblasts J. Bone Miner. Res. 20 2005 41 49
21. R.C. Riddle, A.F. Taylor, J.R. Rogers, and H.J. Donahue ATP release mediates fluid flow-induced proliferation of human bone marrow stromal cells J. Bone Miner. Res. 22 2007 589 600
22. G. Burnstock Physiology and pathophysiology of purinergic neurotransmission Physiol. Rev. 87 2007 659 797
23. A. Hoebertz, A. Townsend-Nicholson, R. Glass, G. Burnstock, and T.R. Arnett Expression of P2 receptors in bone and cultured bone cells Bone 27 2000 503 510
24. I.R. Orriss, G. Burnstock, and T.R. Arnett Purinergic signalling and bone remodelling Curr. Opin. Pharmacol. 10 2010 322 330
25. R.A. North Molecular physiology of P2X receptors Physiol. Rev. 82 2002 1013 1067
26. B.S. Khakh, and R.A. North P2X receptors as cell-surface ATP sensors in health and disease Nature 442 2006 527 532
27. 7 receptor EMBO J. 25 2006 5071 5082
28. 7 nucleotide receptor reveals its regulatory roles in bone formation and resorption Mol. Endocrinol. 17 2003 1356 1367
29. 7 nucleotide receptor mediates skeletal mechanotransduction J. Biol. Chem. 280 2005 42952 42959
30. N. Panupinthu, L. Zhao, F. Possmayer, H.Z. Ke, S.M. Sims, and S.J. Dixon P2X7 nucleotide receptors mediate blebbing in osteoblasts through a pathway involving lysophosphatidic acid J. Biol. Chem. 282 2007 3403 3412
31. N. Panupinthu, J.T. Rogers, L. Zhao, L.P. Solano-Flores, F. Possmayer, S.M. Sims, and S.J. Dixon P2X7 receptors on osteoblasts couple to production of lysophosphatidic acid: a signaling axis promoting osteogenesis J. Cell Biol. 181 2008 859 871
32. M.A. Frohman, T.C. Sung, and A.J. Morris Mammalian phospholipase D structure and regulation Biochim. Biophys. Acta 1439 1999 175 186
33. D.M. Lapierre, N. Tanabe, A. Pereverzev, M. Spencer, R.P. Shugg, S.J. Dixon, and S.M. Sims Lysophosphatidic acid signals through multiple receptors in osteoclasts to elevate cytosolic calcium concentration, evoke retraction, and promote cell survival J. Biol. Chem. 285 2010 25792 25801
34. A. Del Fattore, A. Teti, and N. Rucci Osteoclast receptors and signaling Arch. Biochem. Biophys. 473 2008 147 160
35. C.Q. Duong, S.M. Bared, A. Abu-Khader, C. Buechler, A. Schmitz, and G. Schmitz Expression of the lysophospholipid receptor family and investigation of lysophospholipid-mediated responses in human macrophages Biochim. Biophys. Acta 1682 2004 112 119
36. B.H. Heasley, R. Jarosz, K.R. Lynch, and T.L. Macdonald Initial structure-activity relationships of lysophosphatidic acid receptor antagonists: discovery of a high-affinity LPA1/LPA3 receptor antagonist Bioorg. Med. Chem. Lett. 14 2004 2735 2740
37. X. Fang, S. Yu, R.C. Bast, S. Liu, H.J. Xu, S.X. Hu, R. LaPushin, F.X. Claret, B.B. Aggarwal, Y. Lu, and G.B. Mills Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells J. Biol. Chem. 279 2004 9653 9661
38. A. Boucharaba, C.M. Serre, S. Gres, J.S. Saulnier-Blache, J.C. Bordet, J. Guglielmi, P. Clezardin, and O. Peyruchaud Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer J. Clin. Invest. 114 2004 1714 1725
39. A. Boucharaba, C.M. Serre, J. Guglielmi, J.C. Bordet, P. Clezardin, and O. Peyruchaud The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases Proc. Natl. Acad. Sci. U. S. A. 103 2006 9643 9648
40. A. Boucharaba, B. Guillet, F. Menaa, M. Hneino, A.J. van Wijnen, P. Clezardin, and O. Peyruchaud Bioactive lipids lysophosphatidic acid and sphingosine 1-phosphate mediate breast cancer cell biological functions through distinct mechanisms Oncol. Res. 18 2009 173 184
41. Y.S. Hwang, S.K. Lee, K.K. Park, and W.Y. Chung Secretion of IL-6 and IL-8 from lysophosphatidic acid-stimulated oral squamous cell carcinoma promotes osteoclastogenesis and bone resorption Oral Oncol. 48 2012 40 48
42. B.K. McMichael, S.M. Meyer, and B.S. Lee c-Src-mediated phosphorylation of thyroid hormone receptor-interacting protein 6 (TRIP6) promotes osteoclast sealing zone formation J. Biol. Chem. 285 2010 26641 26651
43. M. David, E. Wannecq, F. Descotes, S. Jansen, B. Deux, J. Ribeiro, C.M. Serre, S. Gres, N. Bendriss-Vermare, M. Bollen, S. Saez, J. Aoki, J.S. Saulnier-Blache, P. Clezardin, and O. Peyruchaud Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts PLoS One 5 2010 e9741
44. N. Ishida, K. Hayashi, M. Hoshijima, T. Ogawa, S. Koga, Y. Miyatake, M. Kumegawa, T. Kimura, and T. Takeya Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator J. Biol. Chem. 277 2002 41147 41156
45. H. Takayanagi, S. Kim, T. Koga, H. Nishina, M. Isshiki, H. Yoshida, A. Saiura, M. Isobe, T. Yokochi, J. Inoue, E.F. Wagner, T.W. Mak, T. Kodama, and T. Taniguchi Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts Dev. Cell 3 2002 889 901
46. H. Noguchi, M. Matsushita, T. Okitsu, A. Moriwaki, K. Tomizawa, S. Kang, S.T. Li, N. Kobayashi, S. Matsumoto, K. Tanaka, N. Tanaka, and H. Matsui A new cell-permeable peptide allows successful allogeneic islet transplantation in mice Nat. Med. 10 2004 305 309
47. D.E. Hughes, and B.F. Boyce Apoptosis in bone physiology and disease Mol. Pathol. 50 1997 132 137
48. S.G. Rhee Regulation of phosphoinositide-specific phospholipase C Annu. Rev. Biochem. 70 2001 281 312
49. S.R. Neves, P.T. Ram, and R. Iyengar G protein pathways Science 296 2002 1636 1639
50. F. Macian NFAT proteins: key regulators of T-cell development and function Nat. Rev. Immunol. 5 2005 472 484
51. A. Pereverzev, S.V. Komarova, J. Korcok, S. Armstrong, G.B. Tremblay, S.J. Dixon, and S.M. Sims Extracellular acidification enhances osteoclast survival through an NFAT-independent, protein kinase C-dependent pathway Bone 42 2008 150 161
52. N. Tanabe, B.D. Wheal, J. Kwon, H.H. Chen, R.P. Shugg, S.M. Sims, H.A. Goldberg, and S.J. Dixon Osteopontin signals through calcium and nuclear factor of activated T cells (NFAT) in osteoclasts: a novel RGD-dependent pathway promoting cell survival J. Biol. Chem. 286 2011 39871 39881
53. T. Virag, D.B. Elrod, K. Liliom, V.M. Sardar, A.L. Parrill, K. Yokoyama, G. Durgam, W. Deng, D.D. Miller, and G. Tigyi Fatty alcohol phosphates are subtype-selective agonists and antagonists of lysophosphatidic acid receptors Mol. Pharmacol. 63 2003 1032 1042
54. S. Ory, Y. Munari-Silem, P. Fort, and P. Jurdic Rho and Rac exert antagonistic functions on spreading of macrophage-derived multinucleated cells and are not required for actin fiber formation J. Cell Sci. 113 Pt. 7 2000 1177 1188
55. T.J. Chambers, and C.J. Magnus Calcitonin alters behaviour of isolated osteoclasts J. Pathol. 136 1982 27 39
56. 2 + accelerates nuclear translocation of nuclear factor κB in osteoclasts J. Biol. Chem. 278 2003 8286 8293
57. D.A. Wood, L.K. Hapak, S.M. Sims, and S.J. Dixon Direct effects of platelet-activating factor on isolated rat osteoclasts. Rapid elevation of intracellular free calcium and transient retraction of pseudopods J. Biol. Chem. 266 1991 15369 15376
58. Z.G. Zheng, D.A. Wood, S.M. Sims, and S.J. Dixon Platelet-activating factor stimulates resorption by rabbit osteoclasts in vitro Am. J. Physiol. 264 1993 E74 E81
59. M.R. Gravel, Z.G. Zheng, S.M. Sims, and S.J. Dixon Platelet-activating factor induces pseudopod formation in calcitonin-treated rabbit osteoclasts J. Bone Miner. Res. 9 1994 1769 1776
60. H. Hikiji, S. Ishii, H. Shindou, T. Takato, and T. Shimizu Absence of platelet-activating factor receptor protects mice from osteoporosis following ovariectomy J. Clin. Invest. 114 2004 85 93
61. A1 lysophosphatidic acid receptor gene in normal suckling behavior Proc. Natl. Acad. Sci. U. S. A. 97 2000 13384 13389
62. 2 Mol. Cell. Biol. 22 2002 6921 6929
63. I. Gennero, S. Laurencin-Dalicieux, F. Conte-Auriol, F. Briand-Mesange, D. Laurencin, J. Rue, N. Beton, N. Malet, M. Mus, A. Tokumura, P. Bourin, L. Vico, G. Brunel, R.O. Oreffo, J. Chun, and J.P. Salles Absence of the lysophosphatidic acid receptor LPA1 results in abnormal bone development and decreased bone mass Bone 49 2011 395 403
64. Y.B. Liu, Y. Kharode, P.V. Bodine, P.J. Yaworsky, J.A. Robinson, and J. Billiard LPA induces osteoblast differentiation through interplay of two receptors: LPA1 and LPA4 J. Cell. Biochem. 109 2010 794 800
65. 4/p2y9/GPR23 in negative regulation of cell motility Mol. Biol. Cell 19 2008 5435 5445
66. D.P. Trebec, D. Chandra, A. Gramoun, K. Li, J.N. Heersche, and M.F. Manolson Increased expression of activating factors in large osteoclasts could explain their excessive activity in osteolytic diseases J. Cell. Biochem. 101 2007 205 220